Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
American Oriental Bioengineering, Inc.
Chinese biotech firm appoints independent director of company
November 6th, 2004
American Oriental Bioengineering, Inc., (AOBO) announced the appointment of Cosimo J. Patti as an independent director of the company. Patti brings more than 30 years of experience in international finance and management of cross-border operations and sales organizations to the company. Tony Liu, CEO of AOBO, said, "Patti's appointment provides additional depth and dimension to AOBO's Board through his knowledge of best-practice corporate governance procedures and compliance with Sarbanes-Oxley. "This is also part of our preparations to comply with listing requirements of the American Stock Exchange. Patti's experience in...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2004-11-06)
|
